Intellia Therapeutics
NTLA
NTLA
277 hedge funds and large institutions have $934M invested in Intellia Therapeutics in 2025 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 111 increasing their positions, 86 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
1.76% less ownership
Funds ownership: 97.84% → 96.08% (-1.8%)
5% less funds holding
Funds holding: 293 → 277 (-16)
25% less first-time investments, than exits
New positions opened: 40 | Existing positions closed: 53
Holders
277
Holding in Top 10
2
Calls
$18.2M
Puts
$11.2M
Top Buyers
| 1 | +$19.1M | |
| 2 | +$11.2M | |
| 3 | +$7.43M | |
| 4 |
Renaissance Technologies
New York
|
+$6.35M |
| 5 |
TI
Trexquant Investment
Stamford,
Connecticut
|
+$4.9M |
Top Sellers
| 1 | -$26.9M | |
| 2 | -$19.2M | |
| 3 | -$14.2M | |
| 4 |
BlackRock
New York
|
-$4.96M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$4.84M |